Veracyte to Release Second Quarter 2023 Financial Results on August 8, 2023
19 Julho 2023 - 6:00PM
Business Wire
Veracyte, Inc. (Nasdaq: VCYT) announced today that it will
release financial results for the second quarter of 2023 after the
close of market on Tuesday, August 8, 2023. Company management will
host a conference call and webcast to discuss financial results and
provide a general business update at 4:30 p.m. Eastern Time on the
same day.
The conference call will be webcast live from the company’s
website and will be available via the following link:
https://edge.media-server.com/mmc/p/iwy5xkbf. A webcast replay will
be available following the conclusion of the live broadcast and
will be accessible on the company’s website at
https://investor.veracyte.com/events-presentations.
The conference call dial-ins can be accessed by registering at:
https://register.vevent.com/register/BI62f03c15042b4d5dadeed4e37ed31fd8
About Veracyte
Veracyte (Nasdaq: VCYT) is a global diagnostics company whose
vision is to transform cancer care for patients all over the world.
We empower clinicians with the high-value insights they need to
guide and assure patients at pivotal moments in the race to
diagnose and treat cancer. Our high-performing tests enable
clinicians to make more confident diagnostic, prognostic and
treatment decisions for some of the most challenging diseases such
as thyroid, prostate, breast, bladder and lung cancers, as well as
interstitial lung diseases. We help patients avoid unnecessary
procedures and speed time to diagnosis and appropriate treatment.
In addition to making our tests available in the U.S. through our
central laboratories, we also aim to deliver our tests to patients
worldwide through a distributed model to laboratories that can
perform them locally. Veracyte is based in South San Francisco,
California. For more information, please visit www.veracyte.com and
follow the company on Twitter (@veracyte).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230719721261/en/
Investors Shayla Gorman - Director, Investor Relations
investors@veracyte.com (619) 393-1545
Media Tracy Morris - Vice President of Global Corporate
Communications tracy.morris@veracyte.com (650) 380-4413
Veracyte (NASDAQ:VCYT)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Veracyte (NASDAQ:VCYT)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024